from March 27-30, 2025. Among the highlights is the newly FDA 510(k)-cleared Ossera™ AFX Ankle Fusion System, engineered to advance fusion procedures through cutting-edge 3D printing and TIDAL ...

Union rate did not differ between patients who received allograft, autograft or no biologic adjuvant during foot and ankle arthrodesis. Mean time to fusion also did not significantly differ.